Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 15/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | HTR1D | P28221 | 1/20 | 0.31 |
| ▸ | HTR1B | P28222 | 1/20 | 0.31 |
| ▸ | KIF18A | Q8NI77 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23186865 | 0.83 | PTPN11 (0.52) | PTPN11KCNH2EGFR | |
| SCHEMBL23186812 | 0.81 | PTPN11 (0.49) | PTPN11KCNH2EGFR | |
| SCHEMBL23186809 | 0.81 | PTPN11 (0.46) | PTPN11KCNH2EGFR | |
| SCHEMBL23186864 | 0.81 | PTPN11 (0.39) | PTPN11KCNH2EGFRSCN10A | |
| SCHEMBL23186828 | 0.79 | PTPN11 (0.41) | PTPN11KCNH2EGFR | |
| SCHEMBL21154444 | 0.76 | PTPN11 (0.58) | PTPN11KCNH2EGFR | |
| SCHEMBL23186853 | 0.75 | PTPN11 (0.71) | PTPN11 | |
| SCHEMBL23186859 | 0.74 | PTPN11 (0.39) | PTPN11KIF18A | |
| SCHEMBL19785059 | 0.74 | PTPN11 (0.50) | PTPN11KCNH2 | |
| SCHEMBL19785588 | 0.73 | PTPN11 (0.55) | PTPN11KCNH2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018013597-A1 | 2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS | Revolution Medicines, Inc. (US) | 2018-01-18 | — | — | WO | disclosed |